2026 · Poster Presentation · University of Alabama Birmingham · Dermatology
Keith D. Knapp
Publications
15
Total Publications
2025 · Poster Presentation · AbbVie Inc. · Dermatology
Correlation between achieving SALT 20 score and clinician- and patient-reported outcomes among patients diagnosed with alopecia areata in the US: An assessment from the TARGET-DERM AA registry
Read more →2025 · Poster Presentation · Northwestern University · Dermatology
Race and ethnicity sub-groups of alopecia areata patients have differing clinical characteristics: TARGET-DERM AA
Read more →2025 · Poster Presentation · AbbVie Inc. · Dermatology
Generic vs. disease-specific patient reported outcome (PRO) instruments for assessing HRQoL burden among patients diagnosed with alopecia areata: Evidence from TARGET-DERM AA
Read more →2025 · Abstract/Manuscript · Northwestern University
Unmet Needs of Effective Advanced Systemic Therapies in Moderate-to-Severe Atopic Dermatitis Patients in the TARGET-DERM AD Registry
Read more →2024 · Poster Presentation · Medical University of South Carolina · Dermatology
Demographics and disease characteristics of patients with alopecia areata with comorbid atopic dermatitis, vitiligo or anxiety/depression: TARGET-DERM AA
Read more →2024 · Poster Presentation · George Washington University · Dermatology
Why Do Optimal Targets for Itch and Skin Clearance Matter in Atopic Dermatitis Treatment? Insights from the TARGET-DERM AD Registry
Read more →2024 · Poster Presentation · Novartis AG · Dermatology
Real-world study of hidradenitis suppurativa: skin lesions and pain are associated with Hurley Stage in TARGET-DERM HS
Read more →2024 · Poster Presentation · Wake Forest University School of Medicine · Gastroenterology
Predictors of Patients Receiving No Medication for Treatment of Eosinophilic Esophagitis in the United States: Data from the TARGET-EGIDS Cohort
Read more →2024 · Poster Presentation · Wake Forest University School of Medicine · Gastroenterology
Time to Diagnosis Among Patients with Eosinophilic Esophagitis in the United States
Read more →2024 · Oral Presentation · Novartis AG · Dermatology
Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA
Read more →2024 · Poster Presentation · AbbVie Inc. · Dermatology
Persistent Inadequate Disease Control and Therapeutic Inertia in Moderate-to-Severe Atopic Dermatitis: A 12-month Longitudinal Analysis of Real-world Outcomes from the TARGET-DERM AD registry (Fall Clinical 2024)
Read more →2024 · Poster Presentation · AbbVie Inc. · Dermatology
Impact of Therapeutic Inertia on Patient-Reported Outcomes in Moderate-to-Severe Atopic Dermatitis: A 12-Month Longitudinal Study from the TARGET-DERM AD Registry (RAD Winter 2023)
Read more →2023 · Poster Presentation · AbbVie Inc. · Dermatology